Pediatric PH Resources
The PPHNet does not specifically endorse any of the commercial products mentioned in the Patient Resource brochures, nor does the PPHNet receive any financial contributions from the manufacturers of the commercial products named. Pulmonary vasodilators mentioned in the brochures are all approved by the US Food and Drug Agency for adult pulmonary arterial hypertension, with the exception of a phosphodiesterase inhibitor (sildenafil) and an endothelin receptor antagonist (bosentan) which have been approved for use in some children.